Mascoma Wealth Management’s Rentokil RTO Stock Holding History

Mascoma Wealth Management’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572	Buy	+20	New	+$635	﹤0.01%	543

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Mascoma Wealth Management's RTO Position: Q2 2026 in Review

Mascoma Wealth Management opened a new position in Rentokil (RTO) in Q2 2026: 20 shares worth $572. The stake represents ﹤0.01% of the portfolio and ranks #543 among its holdings.

284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

Mascoma Wealth Management held 20 shares of Rentokil worth $572 as of Q2 2026.
Rentokil was a new Mascoma Wealth Management position in Q2 2026.
Rentokil made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #543 holding.
284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.